Fig 3.

Mean change from baseline in WLQ productivity loss score through Week 52 among patients who were working or volunteering full or part time (n=219). Change from baseline is based on imputed data using LOCF for missing data. Patients with no value at baseline are excluded from the analysis. The adjusted p values are based on ANCOVA controlling for baseline MTX usage (yes, no) and baseline WLQ productivity loss score. ANCOVA, analysis of covariance; LOCF, last observation carried forward; LSMD, least square mean difference; GLM, golimumab; IV, intravenous; MTX, methotrexate; n, number of patients; PBO, placebo; WLQ, Work Limitations Questionnaire